BioNTech SE

Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases.

Lobbying Activity

Meeting with Cecile Billaux (Head of Unit Directorate-General for International Partnerships)

10 Jul 2025 · BioNTech mRNA Vaccine Manufacturing Facility in Rwanda and HDX

Meeting with Ekaterina Zaharieva (Commissioner) and

25 Jun 2025 · - Startup and Scaleup Strategy and Scaleup Europe Fund - Life Sciences Strategy

Meeting with Koen Doens (Director-General Directorate-General for International Partnerships) and

25 Jun 2025 · Global Gateway Agenda on Health

Meeting with Martin Seychell (Deputy Director-General Directorate-General for International Partnerships) and

16 May 2025 · Vaccine development and manufacturing in Africa

Meeting with Martin Seychell (Deputy Director-General Directorate-General for International Partnerships) and

7 May 2025 · Update on Mpox clinical development and R&D and manufacturing landscape for Africa

Meeting with Daphne Von Buxhoeveden (Head of Unit Health Emergency Preparedness and Response Authority), Wolfgang Philipp (Principal Adviser Health Emergency Preparedness and Response Authority)

7 May 2025 · Update on Mpox clinical development and R&D and manufacturing landscape for Africa

Meeting with Laurent Muschel (Acting Director-General Health Emergency Preparedness and Response Authority)

11 Dec 2024 · Pipeline presentation

Meeting with Koen Doens (Director-General Directorate-General for International Partnerships)

22 Feb 2024 · Presentation of their global health activities

Meeting with Stelios Kympouropoulos (Member of the European Parliament) and Moderna, Inc.

17 Jan 2024 · Kangaroo Lunch debate on Platform Technologies and the pharmaceutical legislation review

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and Moderna, Inc.

16 Jan 2024 · Pharmaceutical legislation

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and Moderna, Inc.

30 Oct 2023 · Pharmaceutical Package (Directive)

Meeting with Tiemo Wölken (Member of the European Parliament) and

18 Oct 2023 · Pharma Revision - Directive (staff level)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and

13 Oct 2023 · Directive on Medicinal products for human use

Meeting with Véronique Trillet-Lenoir (Member of the European Parliament)

21 Sept 2022 · COVI delegation

Meeting with Ursula von der Leyen (President)

6 Jan 2022 · Meeting with CEO of BioNTech

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

6 May 2021 · Site visit and assessment of production capacity and supply chain

Meeting with Ursula von der Leyen (President) and

31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements